TW200738640A - Substituted pyrazoline compounds, their preparation and use as medicaments - Google Patents
Substituted pyrazoline compounds, their preparation and use as medicamentsInfo
- Publication number
- TW200738640A TW200738640A TW095125891A TW95125891A TW200738640A TW 200738640 A TW200738640 A TW 200738640A TW 095125891 A TW095125891 A TW 095125891A TW 95125891 A TW95125891 A TW 95125891A TW 200738640 A TW200738640 A TW 200738640A
- Authority
- TW
- Taiwan
- Prior art keywords
- preparation
- medicaments
- substituted pyrazoline
- pyrazoline compounds
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05384018A EP1743888A1 (en) | 2005-07-15 | 2005-07-15 | Carbonyl substituted pyrazoline compounds, their preparation and use as CB1 receptor modulators |
US70543305P | 2005-08-05 | 2005-08-05 | |
EP06008612A EP1849776A1 (en) | 2006-04-26 | 2006-04-26 | Azepane- or Azocane-substituted pyrazoline compounds, their preparation and use as medicaments |
EP06008580A EP1849775A1 (en) | 2006-04-26 | 2006-04-26 | Cycloalkane-substituted pyrazoline compounds, their preparation and use as medicaments |
EP06008581A EP1849784A1 (en) | 2006-04-26 | 2006-04-26 | Indoline-substituted pyrazoline compounds, their preparation and use as medicaments |
EP06008579A EP1849783A1 (en) | 2006-04-26 | 2006-04-26 | Octahydropentalene-substituted pyrazoline compounds, their preparation and use as medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200738640A true TW200738640A (en) | 2007-10-16 |
Family
ID=43298612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095125891A TW200738640A (en) | 2005-07-15 | 2006-07-14 | Substituted pyrazoline compounds, their preparation and use as medicaments |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR062543A1 (zh) |
PE (1) | PE20070178A1 (zh) |
TW (1) | TW200738640A (zh) |
-
2006
- 2006-07-14 PE PE2006000850A patent/PE20070178A1/es not_active Application Discontinuation
- 2006-07-14 TW TW095125891A patent/TW200738640A/zh unknown
- 2006-07-14 AR ARP060103040A patent/AR062543A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR062543A1 (es) | 2008-11-19 |
PE20070178A1 (es) | 2007-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY140826A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments. | |
TW200745043A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
TW200738699A (en) | 4-Substituted pyrazoline compounds, their preparation and use as medicaments | |
WO2007009720A3 (en) | Prodrugs of pyrazoline compounds, their preparation and use as medicaments | |
WO2008043544A8 (en) | Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators | |
MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
TN2011000263A1 (en) | Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease | |
ATE453642T1 (de) | Substituierte phenylaminopyrimidine | |
TNSN04203A1 (en) | Benzoxazinone-derived compounds, their preparation and use as medicaments | |
TW200745042A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
WO2007098964A3 (en) | Pyrrazole derivatives as sigma receptors antagonists | |
MX2009010374A (es) | Derivados de tetrahidro-naftalenamina sustituidos con heterociclilo, su preparacion y su uso como medicamentos. | |
WO2009003719A3 (en) | Indane-amine derivatives, their preparation and use as medicaments | |
MX2008011020A (es) | Compuestos de receptor sigma. | |
MX2009013482A (es) | Derivados de [1,10]-fenantrolina para el tratamiento de enfermedades neurodegenerativas o hematologicas. | |
MX2009005912A (es) | Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos. | |
MX2009008176A (es) | Derivados de tetrahidro-naftaleno sustituidos con heterociclos, su preparacion y su uso como medicamentos. | |
MX2008013477A (es) | Compuestos biciclicos de tetrahidropirrol. | |
BRPI0507745A (pt) | compostos de azetidina substituìda como inibidores de ciclooxigenase-1-ciclooxigenase-2, processo para a sua preparação, medicamentos e seus usos | |
TW200734335A (en) | Compounds | |
WO2006138589A3 (en) | Opioid receptor ligands | |
MY136965A (en) | 1,4-disubstituted piperidine compounds, their preparation and use as medicaments | |
TW200738640A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
WO2007009711A3 (en) | Octahydropentalene-substituted pyrazoline compounds, their preparation and use as medicaments | |
WO2007009706A3 (en) | Substituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood |